FDA Import Refusal 799-8838116-7/13/1 — Abbvie Corporation

Abbvie Corporation — FEI 3010173015

The FDA refused shipment 799-8838116-7/13/1 from Abbvie Corporation (Canada) on Jul 2, 2025. The refused product falls under Drugs and Biologics — UPADACITINIB (ANTI-RHEUMATIC). Cited charge: 75 This firm has 5 or more other import refusals on record.